Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 10Stomach Neoplasms 8Neoplasm Metastasis 6Colorectal Neoplasms 6Breast Neoplasms 6Nasopharyngeal Carcinoma 5Leukemia, Myeloid, Acute 5Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mouth Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Carcinoma, Squamous Cell 2Anatomic Stage II Breast Cancer AJCC v8 2Advanced Solid Tumors 2Unresectable Locally Recurrent Rectal Cancer 1Thymoma 1

Interventions

Radiosurgery 2Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unresectable Locally Recurrent Rectal Cancer × Drug Therapy × 90 days × Clear all
NCT06767007 2026-04-23

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE)

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
31 enrolled
Gastrointestinal

Unresectable Locally Recurrent Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡